2022 annual financial data
Adaptive Biotechnologies 2022 Operating margin
Adaptive Biotechnologies 2022 operating margin with verified reported values.
Direct answer
Operating margin was -108.03%.
Operating income was -200,186,000 USD and net income was -200,191,000 USD.
Operating cash flow was -183,945,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 185,308,000 USD
- Operating income
- -200,186,000 USD
- Net income
- -200,191,000 USD
- Operating cash flow
- -183,945,000 USD